InvestorsHub Logo
icon url

exwannabe

08/21/20 6:30 PM

#301492 RE: hyperopia #301485

Ok, so the PIM designation is still active. Wonderful.

IF NWBO actually submits the material to get the scientific opinion, they could be blessed with the EAMS designation.

And then NWBO could provide DCVa-L for free as they can not charge for it.

Now, given that please tell me why this is anything of value? Hell, LP would be canabalizing here modest Specials revenue.
icon url

H2R

08/22/20 5:03 AM

#301514 RE: hyperopia #301485

Doc. Ashkan back in the the 2018 ASCO talk saidhe was looking to get DCVax L ASAP.
(he starts around minute 46)

With PIM in play, he might be able to get DCVax L to patients faster than with other route.

If Sawston is indeed being ramped up for production and 'good' TLD, patients may start to be able to get a game changer treatment against this dreadful disease.

Best of luck to Patients, NWBO, and Longs!